Announcement on Obtaining Drug Registration Certificate by Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate by Subsidiary
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang Jianfeng Group Co. Ltd. on 6ix
Earlier from Zhejiang Jianfeng
- Announcement on Overdue Financial Assistance Provided by a Subsidiary
- Announcement on Resignation of Directors
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Report for Q1 2026
Later from Zhejiang Jianfeng
- Zhe Jiang Jian Feng Group Co., Ltd.: Announcement on Subsidiary Obtaining the Approval Notice for Drug Supplementary Application
- Zhe Jiang Jian Feng Group Co., Ltd.: Announcement on Implementation of Dividend Distribution for 2025
- Zhe Jiang Jian Feng Group Co., Ltd.: Announcement on Inclusion of the Subsidiary's Products in the "National Essential Medicines List (2026 Edition)"
- Zhe Jiang Jian Feng Group Co., Ltd.: Announcement on Expected Loss in Semi-annual Performance for 2026
- Zhe Jiang Jian Feng Group Co., Ltd.: Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Zhejiang Jianfeng into a list and get an email when it puts out news.
Follow Zhejiang Jianfeng